Edition:
United States

Kiwa Bio-Tech Products Group Corp (KWBT.PK)

KWBT.PK on OTC Markets Group

2.74USD
--
Change (% chg)

-- (--)
Prev Close
$2.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,272
52-wk High
$3.00
52-wk Low
$0.62

Summary

Name Age Since Current Position

Wei Li

54 2015 Chairman of the Board

Yvonne Wang

37 2016 Chief Operating Officer, Corporate Secretary, Acting President, Acting Chief Executive Officer, Acting Chief Financial Officer, Principal Executive Officer, Principal Financial and Accounting Officer

Qi Wang

48 2007 Vice President - Technical, Director

Lianjun Luo

45 2008 Director

Yong Lin Song

2017 Director

Xucheng Hu

56 2008 Independent Director

Xin Ma

38 2010 Associate Chief Financial Officer

Biographies

Name Description

Wei Li

Mr. Wei Li is an Chairman of the Board of the Company. He was President, Chief Executive Officer of Kiwa Bio-Tech Products Group Corporation. He appointed as Chief Financial Officer on January 4, 2009 by the Board of Directors. From January 1, 2004 to the time of the Tintic/Kiwa merger, Mr. Li was the acting Chief Executive Officer of Kiwa Bio-Tech Products Group Ltd. Mr. Li founded Kiwa Bio-Tech Products Group Ltd. to capitalize on the growth of the ag-biotechnology industry in China. Prior to founding Kiwa Bio-Tech Products Group Ltd., Mr. Li founded China Star, an entity which provides integrated financial services and/or venture investments to growth businesses in China. Mr. Li served as President of China Star from June 1993 to January 2004. In 1989, Mr. Li founded Xinhua International Market Development Co. Ltd., a company which engaged in investing in China’s high tech, pharmaceutical, medical device, media, entertainment and real estate industries. Mr. Li holds a B.S. in Finance from Hunan Finance and Economics University. Mr. Li has a wealth of experience in running businesses in China, with broad management expertise and a knowledge and understanding of business issues in China, and is able to provide the Board of Directors with his insights and experience in running businesses in China.

Yvonne Wang

Ms. Yvonne Wang serves as Chief Operating Officer, Corporate Secretary, Acting President, Acting Chief Executive Officer, Acting Chief Financial Officer, Principal Executive Officer, Principal Financial and Accounting Officer of Kiwa Bio-Tech Products Group Corporation. Prior to that, she served as an executive assistant and a manager of the Company’s U.S. office between April 2003 and September 2005. She obtained her B.S. degree of Business Administration in July 2001 from University of Phoenix. She is also a California Realtor, and a certified Notary Public.

Qi Wang

Professor Qi Wang is Vice President - Technical, Director of Kiwa Bio-Tech Products Group Corporation. He has also acted as Director of Kiwa-CAU R&D Center since July 2006. Prof. Wang served as a Professor and Advisor for Ph.D. students in the Department of Plant Pathology, China Agricultural University (“CAU”) since January 2005. Prior to that, he served as an assistant professor and lecturer of CAU since June 1997. He obtained his master degree and Ph.D. in agricultural science from CAU in July 1994 and July 1997, respectively. Prof. Wang received his bachelor’s degree of science from Inner Mongolia Agricultural University in July 1989. He is a committee member of various scientific institutes in China, including the National Research and Application Center for Increasing-Yield Bacteria, Chinese Society of Plant Pathology, Chinese Association of Animal Science and Veterinary Medicine. Prof. Wang’s unique expertise in the field of agriculture offers significant knowledge and experience to the Board of Directors when making critical operational decisions.

Lianjun Luo

Mr. Lianjun Luo is Director of Kiwa Bio-Tech Products Group Corporation. From January 2009 to present, Mr. Luo is a Partner of Beijing Pucheng Law Office. He served as the Chief Executive Officer of Kiwa Bio-Tech Products Group Ltd. from October 2002 to December 2003. From January 2002 to October 2002, Mr. Luo served as the Chief Financial Officer of China Star. From August 2000 to December 2001, Mr. Luo served as manager of Security Department and Assistant to President at Jilin Hengfa Group Ltd., a Chinese drug manufacturing company, responsible for the company’s preparation for an aborted IPO and for merger and acquisition activities. From May 1998 to July 2000, Mr. Luo worked as manager of Investment Department and Associate General Manager for Hongli Enterprise Ltd., a Chinese investment company on merger and acquisition transactions. Mr. Luo obtained his law degree from China University of Political Science and Law in 1993. Mr. Luo is a certified public accountant and lawyer in China. Mr. Luo’s expertise in the field of accounting and law enables him to provide the Company’s Board of Directors with insight and information related to the Company’s financial, accounting and SEC reporting issues.

Yong Lin Song

Mr. Yong Lin Song is Director of the company. Mr. Song is a senior agronomist at the Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences. He has 29 years of experience in microbial R&D and technology promotion and has led many national agricultural projects. In 2001, he was responsible for technological achievement transformation and technology promotion of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences. In 2009, he served as deputy secretary general of the Chinese Society of Plant Nutrition and Fertilizer Science. Mr. Song joined Kiwa in March 2016 and is responsible for the Company’s Research and Development operations.

Xucheng Hu

Mr. Xucheng Hu is Independent Director of Kiwa Bio-Tech Products Group Corporation. since December 30, 2008. Since August 2003, he has been the Executive Director of New Capital International Investment Limited, a listed company on the Hong Kong Stock Exchange. Prior to that engagement, Mr. Hu acted as Executive Director of China Property Development (Holdings) Limited and Asia Director of ING Real Estate. Over the past 10 years, he has been working with the Beijing International Trade Association and the Beijing International Trade Research Institute, during which period his responsibilities included performing financial and economic research and providing professional advice on the Beijing municipal government’s cross-provincial investments and foreign investments, participating in the decision-making process for granting export rights to Beijing government-owned enterprises, evaluating investment proposals, and supervising sino-foreign investments in Beijing. Mr. Hu graduated with a bachelor degree in economics from Beijing Economics College in 1983. Mr. Xu’s experience working with public companies in China enables him to provide the Board with an understanding of the operation of other boards of directors.

Xin Ma

Mr. Xin Ma was Vice President of Kiwa Bio-Tech Products Group Corporation since January 4, 2009. Prior to that Mr. Ma was Associate Chief Financial Officer in January 2006. Prior to that Mr. Ma served as financial controller of LangChao Group. He obtained his MSc. Degrees of Management and of Finance in 2005 and 2006 respectively from the University of Leicester.

Basic Compensation

Name Fiscal Year Total

Wei Li

72,000

Yvonne Wang

--

Qi Wang

19,449

Lianjun Luo

48,000

Yong Lin Song

--

Xucheng Hu

--

Xin Ma

60,000
As Of  30 Dec 2014

Options Compensation